Overview

Company vision

Embrace brilliant life with gene health!

Company mission

Make gene drug development more efficient and low-cost, and promote the development of genetic science and health medicine.

Company profile

Scinosen was born in response to the implementation of MAH (Drug Marketing Authorization Holder) system in China, and is the only professional company in the field of gene medicine in China to achieve full coverage from research and development, industrialization to clinical application.

Scinosen scientists team and industrialization core team - is the world's first gene drug (Gendicine) founder, established a complete recombinant adenovirus biological products large-scale production process technical standards and quality control technical standards. These standards have established China's global leading position in the field of large-scale industrialization of adenovirus gene therapy drugs. It has established drug production quality management norms that comply with China's NMPA, the US FDA and the EU EMA.

Based on the core team's more than 20 years of experience in the field of gene medicine, Scinosen focuses on providing professional viral vector gene medicine CDMO services for the world.